]i and induced an outwardly directed current as measured in whole cell patch-clamp experiments. Dexamethasone significantly augmented the increase of [Ca 2ϩ ]i and the outward current following removal of extracellular Na ϩ . The NCX blocker KB-R7943 reversed the inhibitory effect of dexamethasone on LPS-induced increase in [Ca 2ϩ ]i. Dexamethasone blunted LPS-induced stimulation of CD86 expression and TNF-␣ production, an effect significantly less pronounced in the presence of NCX blocker KB-R7943. In conclusion, our results show that glucocorticoid treatment blunts LPS-induced increase in [Ca 2ϩ ]i in DCs by increasing expression and activity of Na ϩ /Ca 2ϩ exchanger NCX3. The effect contributes to the inhibitory effect of the glucocorticoid on DC maturation.
blunted by overnight incubation with 10 nM dexamethasone before LPS treatment. Dexamethasone did not affect the Ca 2ϩ content of intracellular stores, sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)2 and SERCA3 expression, ryanodine receptor (RyR)1 expression, or Ca 2ϩ entry through store-operated Ca 2ϩ channels. In contrast, dexamethasone increased the transcript level and the membrane protein abundance of the Na ϩ /Ca 2ϩ exchanger NCX3. The activity of Na ϩ /Ca 2ϩ exchangers was assessed by removal of extracellular Na ϩ in the presence of external Ca 2ϩ , a maneuver triggering the Ca 2ϩ influx mode. Indeed, Na ϩ removal resulted in a rapid transient increase of [Ca 2ϩ ]i and induced an outwardly directed current as measured in whole cell patch-clamp experiments. Dexamethasone significantly augmented the increase of [Ca 2ϩ ]i and the outward current following removal of extracellular Na ϩ . The NCX blocker KB-R7943 reversed the inhibitory effect of dexamethasone on LPS-induced increase in [Ca 2ϩ ]i. Dexamethasone blunted LPS-induced stimulation of CD86 expression and TNF-␣ production, an effect significantly less pronounced in the presence of NCX blocker KB-R7943. In conclusion, our results show that glucocorticoid treatment blunts LPS-induced increase in [Ca 2ϩ ]i in DCs by increasing expression and activity of Na ϩ /Ca 2ϩ exchanger NCX3. The effect contributes to the inhibitory effect of the glucocorticoid on DC maturation.
NCX; calcium; glucocorticoids; immunosuppression DENDRITIC CELLS (DCs) play a central role in immune regulation, ranging from mediation of tolerance induction to the initiation of specific immune responses (5) . Glucocorticoids, such as dexamethasone, are powerful regulators of the immune response (13, 15, 24, 37, 38) . They are partially effective by inhibiting DC maturation and function (14, 15, 17, 27, 39, 46, 47) . After exposure to glucocorticoids, DCs show a decreased ability to present antigens and elicit a T-cell response, primarily because glucocorticoids prevent the upregulation of major histocompatibility complex (MHC) class II and costimulatory molecules (15) . Moreover, glucocorticoids impair the production of several cytokines by DCs, including interleukin (IL)-6, IL-12, and tumor necrosis factor (TNF)-␣ (13, 14) . The endocytic activity of DCs is enhanced by glucocorticoids (36) , which is in line with the immature phenotype of glucocorticoid-treated DCs with high antigen capture, low antigen presentation, and decreased ability to stimulate T cells.
At the level of gene expression, glucocorticoids exert their effects by binding to the glucocorticoid receptor, a liganddependent transcription factor. The glucocorticoid receptor is a member of a large superfamily that includes receptors for other steroid hormones, thyroid hormone, vitamin D 3 , retinoic acid, and a number of orphan receptors (38) . The molecular mechanisms involved in the impairment of DC maturation are largely unknown. Glucocorticoids have been shown to induce expression of the B inhibitor (IB) that subsequently traps the active NF-B, thus turning off NF-B-driven gene transcription (3, 40) . Moreover, the glucocorticoid-induced leucine zipper gene (GILZ), which is overexpressed in dexamethasonetreated cells, was shown to contribute to glucocorticoid-mediated inhibition of NF-B (11) .
DC functions, including maturation, antigen presentation, cytokine production, and migration, depend on Ca 2ϩ signaling (1, 10, 31, 50) . Exposure of DCs to ligands for Toll-like receptors, intact bacteria, and microbial toxins stimulates Ca 2ϩ entry (1, 31, 50) , which is accomplished by Ca 2ϩ releaseactivated Ca 2ϩ channels (21, 31 (41) .
Immunosuppressive effects of glucocorticoids could also, at least partially, be due to an influence on Ca 2ϩ -dependent signaling in DCs. The present study explored the influence of dexamethasone treatment on the regulation of the [Ca 2ϩ ] i in mouse bone marrow-derived DCs.
METHODS
All animal experiments were conducted according to German law for the welfare of animals and were approved by the local Regierungspräsidium.
Cell culture. DCs were cultured from bone marrow of 7-to 11-wk-old female NMRI mice (Charles River, Sulzfeld, Germany). Bone marrow-derived cells were flushed out of the cavities from the femur and tibia with PBS. Cells were then washed twice with RPMI and seeded out at a density of 2 ϫ 10 6 cells per 60-mm dish. Cells were cultured for 6 days in RPMI 1640 (GIBCO, Carlsbad, CA) containing 10% FCS, 1% penicillin-streptomycin, 1% glutamine, 1% nonessential amino acids, and 0.05% ␤-mercaptoethanol. Cultures were supplemented with granulocyte macrophage colony-stimulating factor (GM-CSF; 35 ng/ml, Preprotech Tebu) and fed with fresh medium containing GM-CSF on days 3 and 6. At day 7, Ͼ80% of the cells expressed CD11c, which is a marker for mouse DCs. Experiments were performed on days 7-9 of DC culture. Where indicated, DCs were incubated with dexamethasone (10 nM, Sigma-Aldrich, Taufkirchen, Germany) in the absence or presence of KB-R7943 (10 M, Calbiochem) or patch-clamp experiments were performed with acute administration of KB-R7943 (10 M). Dexamethasone was diluted in ethanol (10 mM stock solution) and KB-R7943 in DMSO (10 mM stock solution), leading to final concentrations of 0.0001% ethanol and 0.1% DMSO.
Immunostaining and flow cytometry. Cells (4 ϫ 10 5 ) were incubated in 100 l of PBS containing 0.1% FCS and fluorochromeconjugated antibodies at a concentration of 10 g/ml. A total of 2 ϫ 10 4 cells were analyzed in each individual experiment. The following antibodies (all from BD Pharmingen, Heidelberg, Germany) were used for staining: FITC-conjugated anti-mouse CD11c, clone HL3 (Armenian hamster IgG1, 2), phycoerythrin (PE)-conjugated antimouse CD86, clone GL1 (rat IgG2a, ), and PE-conjugated rat anti-mouse I-A/I-E, clone M5/114.15.2 (IgG2b, ). After incubation with the respective antibodies for 60 min at 4°C, cells were washed twice and resuspended in the same buffer and subjected to flow cytometry analysis.
Cytokine measurement. TNF-␣ concentrations in DC culture supernatants were determined by using the OptEIA ELISA kit (BD Pharmingen) according to the manufacturer's protocol.
Measurement of intracellular Ca 2ϩ . Fluorescence measurements were carried out with an inverted phase-contrast microscope (Axiovert 100, Zeiss, Oberkochen, Germany). Cells were excited alternatively at wavelength () ϭ 340 or 380 nm, and the light was deflected by a dichroic mirror into either the objective (Fluar ϫ40/1.30 oil, Zeiss, Oberkochen, Germany) or a camera (Proxitronic, Bensheim, Germany). Emitted fluorescence intensity was recorded at ϭ 505 nm, and data acquisition was accomplished with specialized computer software (Metafluor, Universal Imaging, Downingtown, PA). As a measure for the increase of cytosolic Ca 2ϩ activity, the slope and peak of the changes in the 340-to-380 nm ratio were determined for each experiment.
Cells were loaded with fura-2 AM (2 M, Molecular Probes, Göttingen, Germany) for 30 min at 37°C and 5% CO2. Intracellular Ca 2ϩ was monitored before and after addition of LPS from Escherichia coli (Enzo Life Sciences, Lausen, Switzerland) to the Ringer solution (see below). Alternatively, changes in cytosolic Ca 2ϩ were monitored upon depletion of the intracellular Ca 2ϩ stores. Experiments were carried out before and during exposure of the cells to Ca 2ϩ -free solution. In the absence of Ca 2ϩ , the intracellular Ca 2ϩ stores were depleted by inhibition of the vesicular Ca 2ϩ pump by thapsigargin (1 M, Molecular Probes). Readdition of Ca 2ϩ allowed assessment of the store-operated Ca 2ϩ entry. In another series of experiments DCs were exposed to high levels (5 mM) of caffeine (Sigma-Aldrich) in order to activate the release of Ca 2ϩ from the stores (8) . Finally, to study Na ϩ /Ca 2ϩ exchange, changes in cytosolic Ca 2ϩ were determined upon replacement of extracellular Na ϩ by N-methyl-D-glucamine (NMDG). In another series of experiments, DCs were pretreated with 1 M thapsigargin and 10 M ryanodine (Ascent Scientific, Bristol, UK) to block the sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) pump and the ryanodine receptors (RyRs), respectively.
Experiments were performed in Ringer solution containing (in mM) 130 NaCl, 2 CaCl 2, 2 MgCl2, 10 HEPES, and 10 glucose at pH 7.4. The Na ϩ -free solution was identical, except that NaCl was replaced by 130 mM NMDG. Ca 2ϩ -free solution contained (in mM) 130 NaCl, 1.2 MgSO 4, 2 Na2HPO4, 32 HEPES, 0.5 EGTA, and 5 glucose, pH 7.4. For calibration purposes, ionomycin (10 M, Calbiochem) was applied at the end of each experiment.
Patch clamp. Patch-clamp experiments were performed at room temperature in voltage-clamp, fast whole cell mode according to Hamill et al. (18) . Cells were continuously superfused through a flow system inserted into the dish. The bath was grounded via a bridge filled with Ringer solution. Borosilicate glass pipettes (1-to 3-M⍀ tip resistance; GC 150 TF-10, Clark Medical Instruments, Pangbourne, UK), handmade with a microprocessor-driven DMZ puller (Zeitz, Augsburg, Germany), were applied in combination with a MS314 electrical micromanipulator (MW, Märzhäuser, Wetzlar, Germany). The currents were recorded on an EPC-9 amplifier (Heka, Lambrecht, Germany) and analyzed with Pulse software (Heka) and an ITC-16 Interface (Instrutech, Port Washington, NY). Voltage-clamp steps were applied every 2 s to potentials between Ϫ100 and ϩ50 mV from a holding potential of 0 mV. Currents were recorded at an acquisition frequency of 10 kHz, 3 kHz low-pass filtered.
To measure Na ϩ /Ca 2ϩ exchanger-mediated currents, a Na ϩ -based pipette solution was used containing (in mM) 120 NaCl, 40 KCl, 20 TEA-Cl, 2 MgCl2, 2 Mg-ATP, 8 glucose, and 10 HEPES (pH 7.2, CsOH) with 1 M free Ca 2ϩ . The external solution contained (in mM) 130 NaCl, 20 TEA-Cl, 2 MgCl2, 10 glucose, 10 HEPES (pH 7.2, CsOH), and 0.5 EGTA. Na ϩ /Ca 2ϩ exchange currents were elicited by switching to a bath solution that contained (in mM) 130 LiCl, 20 TEA-Cl, 2 MgCl2, 2 CaCl2, 10 glucose, and 10 HEPES (pH 7.2, CsOH).
Real-time polymerase chain reaction. Total RNA was extracted from mouse dendritic cells in TRIzol (Peqlab, Erlangen, Germany) according to the manufacturer's instructions. After DNase digestion reverse transcription of total RNA was performed with random hexamers (Roche Diagnostics, Penzberg, Germany) and SuperScriptII reverse transcriptase (Invitrogen, Carlsbad, CA). Polymerase chain reaction (PCR) amplification of the respective genes was set up in a total volume of 20 l with 40 ng of cDNA, 500 nM forward and reverse primer, and 2ϫ iTaq Fast SYBR Green (Bio-Rad, Hercules, CA) according to the manufacturer's protocol. Cycling conditions were as follows: initial denaturation at 95°C for 2 min, followed by 40 cycles of 95°C for 15 s, 55°C for 15 s, and 68°C for 20 s. For the amplification the following primers were used (5=¡3= orientation): NCX1: forward CAAGCTGGAGGTGATCATCG, reverse TCCA-CAGTGCTCTTGAATTCG; NCX2: forward GCCATCCATCTCT-GCCCTTA, reverse CCTGGGGGACAGATACTCCA; NCX3: forward TGACAGCTGCTAGCCCACA, reverse CTCAGCCTCCA-GAGCTCGAT; RyR1: forward GAGAAAGACGCTACCACCGAG, reverse GAGTGGAAGGTGGTTGGGTC; SERCA1: forward AAGGATCAAGGCTCGGGAC, reverse GATGGAGAGGATGCG-GATGT; SERCA2: forward GCCTTCTGTGGAGACCCTTG, reverse CATCCTGCACACGGACATCT; SERCA3: forward AATGC-GATCGTGGGAGTGT, reverse GGATCACCTTACCCATCTCAGG; TATA binding protein (Tbp): forward CAAGCTGGAGGTGAT-CATCG, reverse TCCACAGTGCTCTTGAATTCG.
Specificity of PCR products was confirmed by analysis of a melting curve. Real-time PCR amplifications were performed on a CFX96 Real-Time System (Bio-Rad), and all experiments were done in duplicate. Amplification of the housekeeping gene Tbp was performed to standardize the amount of sample RNA. Relative quantification of gene expression was achieved with the ⌬⌬C t method (where Ct is threshold cycle) as described previously (35) .
Biotinylation of cells and immunoblotting. DCs (4 ϫ 10 7 cells) were washed twice in 8 ml of ice-cold PBS and subsequently incubated with Sulfo-NHS-SS-Biotin (Pierce Cell Surface Protein Isolation Kit, Rockford, IL) in a final concentration of 0.5 mg/ml for 30 min at 4°C on a rocking platform. Then 500 l of quenching solution was added to each flask to quench the reaction. After being washed twice with PBS 0.1% (wt/vol)-BSA and once with PBS without Ca Statistics. Data are provided as means Ϯ SE; n represents the number of independent experiments. All data were tested for significance with Student's unpaired two-tailed t-test or ANOVA, and only results with P Ͻ 0.05 were considered statistically significant.
RESULTS
In accordance with previous observations (1, 31), LPS treatment of DCs led to a rapid increase in [Ca 2ϩ ] i . However, when DCs were incubated overnight with dexamethasone (10 nM), acute application of LPS (100 ng/ml) resulted in a blunted increase in [Ca 2ϩ ] i compared with untreated cells (Fig. 1, A  and B) .
LPS has been shown to induce a biphasic Ca 2ϩ increase, the primary release of Ca 2ϩ from the stores followed by the entry of extracellular Ca 2ϩ through store-operated Ca 2ϩ channels (SOCs) (1, 31) . To analyze whether dexamethasone influences store content, DCs were transiently exposed to caffeine (5 mM, Fig. 1, C and D) or the stores were passively depleted by inhibition of the SERCA pump with thapsigargin in the absence of extracellular Ca 2ϩ (Fig. 1, E and F) . Both caffeineand thapsigargin-induced increase in [Ca 2ϩ ] i were not statistically different between dexamethasone-treated and untreated DCs (Fig. 1, D and F) . The entry of Ca 2ϩ through SOCs, analyzed upon readdition of extracellular Ca 2ϩ in the continued presence of thapsigargin, was again similar in untreated and dexamethasone-treated cells (Fig. 1, E and G) .
The expression of endoplasmic reticulum (ER) Ca 2ϩ -ATPase (SERCA) and RyR1, which is known to be expressed in DCs (32, 49) , was compared in dexamethasone-treated versus untreated cells (Fig. 1, H and I ). SERCA2 and SERCA3 (but not SERCA1) were highly expressed in DCs (Fig. 1H) . The expression levels of SERCA2, SERCA3, and RyR1 were not changed by dexamethasone (Fig. 1I) .
The blunted increase of Ca 2ϩ could have been due to inhibition of Ca 2ϩ extrusion. Thus we analyzed expression levels of Na ϩ /Ca 2ϩ exchangers NCX1-3 in control DCs as well as dexamethasone-treated DCs. Interestingly, dexamethasone treatment significantly enhanced the transcript levels for the Na ϩ /Ca 2ϩ exchanger NCX3 (Fig. 2A) . Moreover, dexamethasone treatment significantly enhanced the membrane protein abundance of NCX3 (Fig. 2B) .
To measure Na ϩ /Ca 2ϩ exchanger activity, [Ca 2ϩ ] i levels were analyzed upon removal of external Na ϩ in the presence of external Ca 2ϩ , thereby reversing the driving force for the carrier and inducing a carrier-mediated Ca 2ϩ entry (2). As illustrated in Fig. 3 , an increase in [Ca 2ϩ ] i was observed as response to the removal of external Na ϩ . Overnight treatment of DCs with 10 mM dexamethasone before Na ϩ depletion led to a fulminant upregulation of the Na ϩ /Ca 2ϩ exchanger activity (Fig. 3) . The effect of dexamethasone was observed when measured in the solution in the absence of external K ϩ , indicating that a K ϩ -independent Na ϩ /Ca 2ϩ exchanger was involved. The upregulation of NCX activity by dexamethasone was reversed when DCs were incubated with dexamethasone in the presence of the pharmacological NCX blocker KB-R7943 (Fig. 3B) . Since the rate of NCX-mediated Ca 2ϩ entry mode could depend on the Ca 2ϩ content in the ER, the experiments were performed in DCs pretreated with ryanodine (10 M) and thapsigargin (1 M) to Ca 2ϩ -deplete the ER (8). Ca 2ϩ entry through NCX was similarly enhanced by dexamethasone in DCs pretreated with ryanodine and thapsigargin (Fig. 3C) .
In an additional series of experiments, the patch clamp technique was applied to determine Na ϩ /Ca 2ϩ exchangerinduced currents. Removal of extracellular Ca 2ϩ in the presence of extracellular Na ϩ forced the carrier into the Ca 2ϩ efflux mode, and, conversely, removal of external Na ϩ in the presence of external Ca 2ϩ converted the carrier into the Ca 2ϩ influx mode. Whole cell membrane currents were recorded continuously at Ϫ80 mV during the exchange of solutions (Fig. 4) . Irrespective of the bath solutions, negative currents were recorded at negative membrane potentials. Removal of extracellular Na ϩ in the presence of Ca 2ϩ generated an upward shift, which was reversed upon readdition of Na ϩ and removal of Ca 2ϩ . The outward current was estimated as the difference in currents elicited by the switch from Na ϩ -containing, Ca 2ϩ -free solutions to Na ϩ -free, Ca 2ϩ -containing solutions (Fig. 4B ). Acute application of KB-R7943 resulted in a 57 Ϯ 6% (n ϭ 8) inhibition of the current (Fig. 4A) . Similar to the observations on [Ca 2ϩ ] i , the Na ϩ /Ca 2ϩ exchange current was enhanced by overnight treatment of the DCs with dexamethasone when measured in the K ϩ -free bath solution (Fig. 4B ). Next, we tested whether KB-R7943 could counteract the dexamethasone-induced decrease in [Ca 2ϩ ] i upon LPS stimulation. As shown in Fig. 5 , incubation of DCs with dexamethasone in the presence of KB-R7943 completely restored and even enhanced the LPS-induced increase in [Ca 2ϩ ] i . Finally, treatment of LPS-stimulated DCs with dexamethasone was followed by a marked decrease of CD86 expres-sion and TNF-␣ production, both effects significantly blunted in the presence of the NCX blocker KB-R7943 (Fig. 6) . The results revealed the involvement of Na ϩ /Ca 2ϩ exchangers in dexamethasone-induced suppression of DC maturation.
DISCUSSION
The present study confirms previous observations (1, 31) that exposure of murine bone marrow-derived DCs to LPS increases cytosolic Ca 2ϩ concentration. LPS has been shown to activate both Ca 2ϩ release from intracellular ER stores and the store-operated entry of extracellular Ca 2ϩ (1, 31, 51 ). The present observations reveal that the glucocorticoid dexamethasone blunts the increase of cytosolic Ca 2ϩ concentrations following LPS treatment. Therefore, the presented work discloses a completely novel effect of this immunosuppressive hormone. The cytosolic Ca 2ϩ level participates in the orchestration of DC-dependent regulation of immune responses and is critically important for DC maturation, migration, cytokine release, and survival (4, 20, 22, 28, 31, 50) .
Our study further investigated the mechanisms accounting for the altered Ca 2ϩ response in dexamethasone-treated DCs. Dexamethasone did not influence the Ca 2ϩ ER store content, since activation of ER Ca 2ϩ release by caffeine as well as passive Ca 2ϩ release upon inhibition of SERCA by thapsigargin were not significantly different between dexametha- ]i increase after addition of LPS were calculated. B: mean Ϯ SE peak (left) and slope (right) of the change in fura-2 fluorescence following addition of LPS to control (n ϭ 7) and dexamethasone (10 nM, overnight)-incubated (n ϭ 7) DCs. Significant difference between 2 groups (2-tailed unpaired t-test): *P Ͻ 0.05, **P Ͻ 0.01. C: representative original tracings showing fura-2 fluorescence ratios in fura-2 AM-loaded control and dexamethasone (10 nM, overnight)-incubated DCs before and after acute addition of caffeine (5 mM; white arrow). For calibration purposes, ionomycin (10 M; black arrows) was added at the end of each experiment. D: mean Ϯ SE peak value (left) and slope (right) of the change in fura-2 fluorescence following addition of caffeine (5 mM) to control (n ϭ 91) and dexamethasone (10 nM, overnight)-incubated (n ϭ 71) DCs. E: representative tracing showing fura-2 fluorescence ratio in fura-2 AM-loaded DCs. Experiments were carried out before and during exposure to nominally Ca 2ϩ -free bath solution. Where indicated, thapsigargin (1 M) was added to the nominally Ca 2ϩ -free bath solution and the release of Ca 2ϩ from the stores was assessed. Readdition of extracellular Ca 2ϩ in the presence of thapsigargin reflects the entry of Ca 2ϩ through store-operated Ca 2ϩ channels (SOCs). F: mean Ϯ SE peak value (left) and slope (right) of the change in fura-2 fluorescence following addition of thapsigargin (1 M) in the absence of extracellular Ca 2ϩ to control (n ϭ 73) and dexamethasone (10 nM, overnight)-incubated (n ϭ 61) DCs. G: mean Ϯ SE peak value (left) and slope (right) of the change in fura-2 fluorescence after readdition of Ca 2ϩ in the continued presence of thapsigargin (1 M) in control (n ϭ 73) and dexamethasone (10 nM, overnight)-incubated (n ϭ 61) DCs. H: agarose gels with PCR products specific for sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA)1-3 amplified from cDNA of mouse DCs treated and untreated with dexamethasone (10 nM, overnight). b.p., base pairs. I: SERCA2, SERCA3, and ryanodine receptor (RyR)1 mRNA levels determined after isolation from dexamethasone-treated and untreated DCs and assessed by real-time PCR using TBP mRNA as a reference gene. Relative mRNA expression is shown as % of increase in dexamethasone-treated vs. control cells (dotted line, 100%) compared with the reference gene (n ϭ 3-6).
sone-treated and untreated cells. Moreover, expression of SERCA2 and SERCA3 and RyR1 were not changed by dexamethasone. Additionally, there was no effect of dexamethasone on Ca 2ϩ entry through SOCs. Instead, dexamethasone did upregulate Na ϩ /Ca 2ϩ exchange. We recently demonstrated (41) that DCs express K ϩ -dependent and K ϩ -independent Na ϩ /Ca 2ϩ exchangers, which rapidly extrude cytosolic Ca 2ϩ . As in other tissues (30, 34, 48) , the Na ϩ /Ca 2ϩ exchangers serve to terminate the increases of the cytosolic Ca 2ϩ levels. A sustained increase of cytosolic Ca 2ϩ would be detrimental, as it would induce apoptosis (6, 33 According to our observations, the influence of dexamethasone on the Na ϩ /Ca 2ϩ exchanger contributes to the inhibitory effect of glucocorticoids on CD86 expression and TNF-␣ production, which in part contribute to the immunosuppressive effects of glucocorticoids. The KB-R7943-insensitive decline of CD86 expression following dexamethasone treatment may be due to mechanisms other than Na ϩ /Ca 2ϩ exchanger activity and/or incomplete inhibition of the Na ϩ /Ca 2ϩ exchanger by the drug.
Effects of glucocorticoids on Ca 2ϩ signaling have previously been reported in other cell types. Glucocorticoids downregulate genes encoding Ca 2ϩ -transporting molecules in the duodenum, resulting in impaired Ca 2ϩ absorption (25) . Specifically, a 5-day treatment with dexamethasone decreases the duodenal expression of transient receptor potential vanilloid 6 (TRPV6) channels, an effect decreasing Ca 2ϩ entry across the apical membrane and thus reducing intestinal Ca 2ϩ absorption (25) . The mRNA level of duodenal Na ϩ /Ca 2ϩ exchanger NCX1 is not altered by dexamethasone (26) . On the other hand, in kidney cells dexamethasone treatment has been shown to increase NCX1 transcript levels, and to reduce the transcript levels of TRPV6 (25) . In other renal cell types dexamethasone did not alter NCX mRNA levels or activity (43) . Dexamethasone (and also cortisol and aldosterone) has been shown to decrease NCX expression and activity in aortic myocytes (42, 44) . The different regulation of NCX by glucocorticoids in distinct tissues may be explained by the model of Lee et al. (29) . According to this model, expression of the same NCX protein is driven by at least three different tissuespecific promoters (29) . Thus tissue or cell type-specific promoter elements may at least partially account for the diverse regulation of NCX expression in response to glucocorticoids.
Dexamethasone is known to rapidly diminish T-cell responses by modulating the pattern of Ca 2ϩ signaling via nm) in fura-2 AM-loaded control and dexamethasone (10 nM, overnight)-incubated DCs before and after removal of external Na ϩ (0 Na ϩ ). Ionomycin (10 M) was added at the end of experiments (black arrow). B: mean Ϯ SE peak value (left) and slope of the increase (right) of the change in fura-2 fluorescence following removal of external Na ϩ in control and 10 nM dexamethasone (overnight)-or 10 nM dexamethasone ϩ 10 M KB-R7943 (overnight)-incubated DCs (n ϭ 25-46). Significant difference between groups (ANOVA): *P Ͻ 0.05, **P Ͻ 0.01. C: mean Ϯ SE peak (left) and slope (right) of the change in fura-2 fluorescence following removal of external Na ϩ in control and dexamethasone (10 nM, overnight)-incubated DCs pretreated with ryanodine (10 M) and thapsigargin (1 M) (n ϭ 13-18). Significant difference between groups (2-tailed unpaired t-test): **P Ͻ 0.01, ***P Ͻ 0.001. (19) . In the case of strong T cell receptor (TCR) stimulation, dexamethasone converted the Ca 2ϩ response from transient increase to sustained oscillations (19) . In contrast, calcium oscillations induced by weak TCR stimulation were decreased by dexamethasone, which was associated with the inhibition of IL-2 induction (19) . Those effects were rapid and mediated by nongenomic inhibition of the Src family kinase Lck (19) , whereas the effects of dexamethasone presented in this study were largely due to a transcriptional activation of NCX.
The present observations reveal that dexamethasone has effects on Na ϩ /Ca 2ϩ exchangers in DCs similar to those of the other immunomodulatory hormone, 1,25(OH) 2 D 3 (41) . However, these two hormones target different subtypes of Na ϩ / Ca 2ϩ exchangers: dexamethasone upregulates K ϩ -independent, whereas 1,25(OH) 2 D 3 upregulates K ϩ -dependent exchangers.
In conclusion, the present study shows that the glucocorticoid dexamethasone stimulates the expression and consequently the activity of Na ϩ /Ca 2ϩ exchangers in bone marrow-derived DCs. Moreover, downregulation of CD86 expression and TNF-␣ production by dexamethasone is, at least partially, NCX dependent. Considering the crucial role of Ca 2ϩ signaling in the regulation of DC function, the stimulation of Ca 2ϩ extrusion most likely plays a significant role in the known immunosuppressive effect of this hormone. Fig. 4 . Effect of dexamethasone on Na ϩ /Ca 2ϩ exchanger currents. A: whole cell currents in untreated DCs and DCs treated with dexamethasone (10 nM, overnight; bottom) recorded at Ϫ80 mV during the switch between external solutions that contained either 130 mM Na ϩ and no Ca 2ϩ (130 Na ϩ , 0 Ca 2ϩ ) or 2 mM Ca 2ϩ and no Na ϩ (0 Na ϩ , 2 Ca 2ϩ ). The internal solution stimulated Na ϩ overload and Ca 2ϩ plateau levels (1 M free Ca 2ϩ , 120 mM Na ϩ ). Cesium and TEA ϩ were present in the solutions to block K ϩ channel currents. Middle: partial inhibition of the current by acute application of KB-R7943 (10 M). Top and middle traces are recorded from the same cell before (control) and after application of KB-R7943. Shown are experiments recorded from cells with similar capacitance. B: mean current density changes (⌬, pA/pF) at Ϫ80 mV induced by the switch between external solutions containing 130 Na ϩ , 0 Ca 2ϩ and 0 Na ϩ , 2 Ca 2ϩ in DCs treated (n ϭ 5) and untreated (control, n ϭ 5) with dexamethasone (10 nM, overnight). The internal solution was as in A. Significant difference between 2 groups (2-tailed unpaired t-test): *P Ͻ 0.05. ]i in fura-2 AM-loaded untreated DCs (control) or DCs overnight treated with either dexamethasone (10 nM) or dexamethasone (10 nM) ϩ KB-R7943 (10 M) before and after acute addition of LPS (100 ng/ml; white arrow). For calibration purposes, ionomycin (10 M; black arrow) was added at the end of each experiment. B: arithmetic mean Ϯ SE peak value (left) and slope (right) of the change in [Ca 2ϩ ]i following addition of LPS in control and dexamethasone (10 nM, overnight)-incubated DCs in the absence or presence of KB-R7943 (10 M) (n ϭ 48 -87). Significant difference between groups (ANOVA): *P Ͻ 0.05, ***P Ͻ 0.001. Fig. 6 . Effect of dexamethasone on CD86 expression and TNF-␣ production is sensitive to the NCX inhibitor KB-R7943. A: arithmetic mean Ϯ SE (n ϭ 6) CD86 expression in LPS (100 ng/ml, 24 h)-stimulated DCs cultured without (control) or with dexamethasone (10 nM, 24 h) in the absence or presence of KB-R7943 (10 M). Difference from control DCs: ***P Ͻ 0.001; difference from dexamethasone-treated cells:
### P Ͻ 0.001 (ANOVA). B: TNF-␣ production in LPS (100 ng/ml, 24 h)-stimulated DCs cultured without (control) or with dexamethasone (10 nM, 24 h) in the absence or presence of KB-R7943 (10 M) as % of TNF-␣ production in LPS-stimulated DCs (n ϭ 6). Difference from control DCs: ***P Ͻ 0.001; difference from dexamethasonetreated cells:
# P Ͻ 0.05 (ANOVA).
